DAFNA Capital Management’s Syneron Medical Ltd ELOS Stock Holding History

DAFNA Capital Management’s Portfolio ELOS Stock Details ELOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-85,947	Closed	-$941K	–	88
2017 Q2	$941K	Hold	85,947	–	–	0.67%	42
2017 Q1	$907K	Hold	85,947	–	–	0.77%	38
2016 Q4	$722K	Hold	85,947	–	–	0.63%	45
2016 Q3	$615K	Hold	85,947	–	–	0.43%	54
2016 Q2	$661K	Hold	85,947	–	–	0.52%	51
2016 Q1	$628K	Hold	85,947	–	–	0.54%	56
2015 Q4	$663K	Hold	85,947	–	–	0.59%	44
2015 Q3	$615K	Sell	85,947 -5,000	-5%	-$48K	0.61%	43
2015 Q2	$966K	Hold	90,947	–	–	0.82%	39
2015 Q1	$1.13M	Hold	90,947	–	–	0.86%	30
2014 Q4	$849K	Hold	90,947	–	–	0.67%	41
2014 Q3	$911K	Hold	90,947	–	–	0.92%	28
2014 Q2	$939K	Hold	90,947	–	–	0.89%	29
2014 Q1	$1.13M	Hold	90,947	–	–	0.97%	22
2013 Q4	$1.12M	Hold	90,947	–	–	1.15%	19
2013 Q3	$784K	Hold	90,947	–	–	0.86%	31
2013 Q2	$791K	Buy	+90,947	New	+$813K	1.16%	24

Other funds holding ELOS

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

LAM

Lapides Asset Management Greenwich, Connecticut $153M AUM 9.03% 1-Year Est. Return

GLAM

Gardner Lewis Asset Management Chadds Ford, Pennsylvania $449M AUM 51.52% 1-Year Est. Return

DAFNA Capital Management's ELOS Position: Q3 2017 in Review

DAFNA Capital Management sold out of Syneron Medical Ltd (ELOS) in Q3 2017, closing a stake of 85,947 shares — an estimated $941K sold.

DAFNA Capital Management first reported a position in ELOS in Q2 2013 and held it in 17 quarters. The position peaked at $1.13M in Q1 2014. 3 funds tracked by Wall St. Rank hold ELOS as of Q3 2017.

DAFNA Capital Management reported no remaining Syneron Medical Ltd position as of Q3 2017 after selling out during the quarter.
DAFNA Capital Management sold 85,947 Syneron Medical Ltd shares in Q3 2017, an estimated $941K.
DAFNA Capital Management first reported a position in Syneron Medical Ltd in Q2 2013 and held it in 17 quarters.
DAFNA Capital Management's Syneron Medical Ltd position peaked at $1.13M in Q1 2014.
3 funds tracked by Wall St. Rank held Syneron Medical Ltd as of Q3 2017.

Based on DAFNA Capital Management's 13F filing for Q3 2017, filed 14 Nov 2017.